Managing AML Patients During COVID-19

  Courtney Dinardo, MD from MD Anderson Cancer Center discusses how the COVID-19 pandemic has affected rare disease patients, particularly in acute myeloid leukemia (AML) patients. AML is an aggressive cancer of the blood and bone marrow with a 5-year survival...

Tenosynovial Giant Cell Tumors (TGCT) Explained

Howard Rutman, MD from Daiichi Sankyo talks about the typical symptoms of tenosynovial giant cell tumors (TGCT).  TGCT are a group of rare, benign tumors that involve the synovium, bursae and/or tendon sheath that can lead to symptoms of pain, swelling, and limitation...